3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Ovarian Neoplasms
2
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hemangiosarcoma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Disease Progression
1
Disease
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Lobular
1
Breast Cancer With Brain Metastasis
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
8
Methotrexate
6
ponatinib
5
fludarabine phosphate
5
merphos
4
Whole-Body Irradiation
4
Tacrolimus
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cytarabine
3
CT-P10
3
Busulfan
3
letermovir
2
blinatumomab
2
Vincristine
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Melphalan
2
Cyclosporine
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
auricularum
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
neratinib
×
1 year
×
Clear all
No trials found.